{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:39:01Z","timestamp":1791157141221,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003962","type":"journal-article","created":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T18:19:14Z","timestamp":1438366754000},"page":"e0003962","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":71,"title":["Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni"],"prefix":"10.1371","volume":"9","author":[{"given":"Gordana","family":"Panic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Scandale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"CJL Murray","year":"2012","journal-title":"The Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(02)00045-1","article-title":"The global epidemiological situation of schistosomiasis and new approaches to control and research","volume":"82","author":"D Engels","year":"2002","journal-title":"Acta Trop"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4269\/ajtmh.2005.72.540","article-title":"Helminth infection and cognitive impairment among Filipino children","volume":"72","author":"AE Ezeamama","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.idc.2012.03.004","article-title":"Schistosomiasis","volume":"26","author":"B Gryseels","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"ref5","first-page":"737","article-title":"Global trends in schistosomiasis control","volume":"86","author":"Myra Taylor","year":"2008","journal-title":"Bull World Health Organ"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1371\/journal.pmed.0030102","article-title":"Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, and malaria","volume":"3","author":"PJ Hotez","year":"2006","journal-title":"PLoS Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"20130434","DOI":"10.1098\/rstb.2013.0434","article-title":"The contribution of mass drug administration to global health: past, present and future","volume":"369","author":"JP Webster","year":"2014","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1586\/14787210.2013.844066","article-title":"Diagnosis and treatment of schistosomiasis in children in the era of intensified control","volume":"11","author":"S Knopp","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pt.2003.09.005","article-title":"Drugs for the control of parasitic diseases: current status and development in schistosomiasis","volume":"19","author":"A Fenwick","year":"2003","journal-title":"Trends Parasitol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00436-012-3151-z","article-title":"Susceptibility or resistance of praziquantel in human schistosomiasis: a review","volume":"111","author":"W Wang","year":"2012","journal-title":"Parasitol Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1016\/S2214-109X(13)70078-0","article-title":"The drug and vaccine landscape for neglected diseases (2000\u201311): a systematic assessment","volume":"1","author":"B Pedrique","year":"2013","journal-title":"Lancet Glob Health"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpddr.2014.07.002","article-title":"Repurposing drugs for the treatment and control of helminth infections","volume":"4","author":"G Panic","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"TT Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0022-3859.81870","article-title":"Drug repositioning: re-investigating existing drugs for new therapeutic indications","volume":"57","author":"BM Padhy","year":"2011","journal-title":"J Postgrad Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1371\/journal.pntd.0000478","article-title":"Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening","volume":"3","author":"M-H Abdulla","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e2610","DOI":"10.1371\/journal.pntd.0002610","article-title":"Orally active antischistosomal early leads identified from the open access Malaria Box","volume":"8","author":"K Ingram-Sieber","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e3435","DOI":"10.1371\/journal.pntd.0003435","article-title":"<italic>In silico<\/italic> repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of <italic>Schistosoma mansoni<\/italic>","volume":"9","author":"BJ Neves","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S0031182009991739","article-title":"<italic>In vitro<\/italic> and <italic>in vivo<\/italic> trematode models for chemotherapeutic studies","volume":"137","author":"J Keiser","year":"2010","journal-title":"Parasitology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/1389557511313040003","article-title":"The evolution of drugs on <italic>Schistosoma<\/italic> treatment: looking to the past to improve the future","volume":"13","author":"Pitta M Galdino da Rocha","year":"2013","journal-title":"Mini-Rev Med Chem"},{"key":"ref20","article-title":"Antimalarials in the treatment of schistosomiasis","author":"J Keiser","year":"2012","journal-title":"Curr Pharm Des"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"KT Andrews","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e1455","DOI":"10.1371\/journal.pntd.0001455","article-title":"A systematically improved high quality genome and transcriptome of the human blood fluke <italic>Schistosoma mansoni<\/italic>","volume":"6","author":"AV Protasio","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref23","first-page":"817","article-title":"Evaluation of the <italic>in vivo<\/italic> effect of ivermectin on <italic>Schistosoma mansoni<\/italic> in experimentally-infected mice","volume":"2","author":"A Taman","year":"2014","journal-title":"J Coast Life Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0035-9203(91)90037-Y","article-title":"A field study of the effect of ivermectin on intestinal helminths in man","volume":"85","author":"JA Whitworth","year":"1991","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2174\/138920112800399257","article-title":"A review on the toxicity and non-target effects of macrocyclic lactones in terrestrial and aquatic environments","volume":"13","author":"J-P Lumaret","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"ref26","author":"SK Attah","year":"2014"},{"key":"ref27","year":"2013"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1128\/AAC.00434-11","article-title":"Apoptosis-inducing activity of clofazimine in macrophages","volume":"55","author":"Y Fukutomi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e4009","DOI":"10.1371\/journal.pone.0004009","article-title":"Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes","volume":"3","author":"YR Ren","year":"2008","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.21.5.693","article-title":"Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy","volume":"21","author":"CE van Rensburg","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejmech.2015.01.065","article-title":"Computer-guided drug repurposing: Identification of trypanocidal activity of clofazimine, benidipine and saquinavir","volume":"93","author":"CL Bellera","year":"2015","journal-title":"Eur J Med Chem"},{"key":"ref32","year":"2015"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-6851(87)90147-2","article-title":"The phospholipid and fatty acid composition of <italic>Schistosoma mansoni<\/italic> and of its purified tegumental membranes","volume":"23","author":"D Allan","year":"1987","journal-title":"Mol Biochem Parasitol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-511X-4-10","article-title":"Role of cholesterol in parasitic infections","volume":"4","author":"D Bansal","year":"2005","journal-title":"Lipids Health Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0166-6851(97)00091-1","article-title":"The incorporation, modification and turnover of fatty acids in adult <italic>Schistosoma mansoni<\/italic>","volume":"88","author":"JFHM Brouwers","year":"1997","journal-title":"Mol Biochem Parasitol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1017\/S0031182007003174","article-title":"Evaluation of cholesterol content and impact on antigen exposure in the outer lipid bilayer of adult schistosomes","volume":"134","author":"H Tallima","year":"2007","journal-title":"Parasitology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e87594","DOI":"10.1371\/journal.pone.0087594","article-title":"Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis","volume":"9","author":"L Rojo-Arreola","year":"2014","journal-title":"PLoS ONE"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e1003942","DOI":"10.1371\/journal.ppat.1003942","article-title":"\u201cDeath and Axes\u201d: Unexpected Ca2+ entry phenologs predict new anti-schistosomal agents","volume":"10","author":"JD Chan","year":"2014","journal-title":"PLoS Pathog"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1590\/0074-0276108052013011","article-title":"Antischistosomal activity of a calcium channel antagonist on schistosomula and adult <italic>Schistosoma mansoni<\/italic> worms","volume":"108","author":"V Silva-Moraes","year":"2013","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e341362","DOI":"10.1155\/2015\/341362","article-title":"Drug repositioning for gynecologic tumors: a new therapeutic strategy for cancer","volume":"2015","author":"K Banno","year":"2015","journal-title":"Sci World J"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1160\/TH08-01-0009","article-title":"Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates","volume":"99","author":"F Gieseler","year":"2008","journal-title":"Thromb Haemost"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","article-title":"Innovative lead discovery strategies for tropical diseases","volume":"5","author":"S Nwaka","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref43","unstructured":"Adverse Reaction Information Unit. Status of terfenadine-containing drugs in Canada [Internet]. Health Canada; 2001 Feb. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/publications.gc.ca\/collections\/Collection\/H30-12-18-2001E.pdf\" xlink:type=\"simple\">http:\/\/publications.gc.ca\/collections\/Collection\/H30-12-18-2001E.pdf<\/ext-link>"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.tips.2013.06.005","article-title":"Cancer drug discovery by repurposing: teaching new tricks to old dogs","volume":"34","author":"SC Gupta","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tube.2004.04.001","article-title":"Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid","volume":"84","author":"DE Nix","year":"2004","journal-title":"Tuberculosis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2746\/042516401776254835","article-title":"Plasma pharmacokinetics and faecal excretion of ivermectin, doramectin and moxidectin following oral administration in horses","volume":"33","author":"C Gokbulut","year":"2001","journal-title":"Equine Vet J"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T06:30:03Z","timestamp":1589005803000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003962"}},"subtitle":[],"editor":[{"given":"Charles","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003962","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,31]]}}}